OpenURL Connection Search

Select item for more details and to access through your institution.

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23331-5
By:
- Giuffrida, Lauren;
- Sek, Kevin;
- Henderson, Melissa A.;
- Lai, Junyun;
- Chen, Amanda X. Y.;
- Meyran, Deborah;
- Todd, Kirsten L.;
- Petley, Emma V.;
- Mardiana, Sherly;
- Mølck, Christina;
- Stewart, Gregory D.;
- Solomon, Benjamin J.;
- Parish, Ian A.;
- Neeson, Paul J.;
- Harrison, Simon J.;
- Kats, Lev M.;
- House, Imran G.;
- Darcy, Phillip K.;
- Beavis, Paul A.
Publication type:
Article
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic.
Published in:
Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 4, p. 359, doi. 10.1111/ajco.13505
By:
- Degeling, Koen;
- Baxter, Nancy N.;
- Emery, Jon;
- Jenkins, Mark A.;
- Franchini, Fanny;
- Gibbs, Peter;
- Mann, G. Bruce;
- McArthur, Grant;
- Solomon, Benjamin J.;
- IJzerman, Maarten J.
Publication type:
Article
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Published in:
2024
By:
- Armstrong, Andrew J.;
- Geva, Ravit;
- Chung, Hyun Cheol;
- Lemech, Charlotte;
- Miller Jr, Wilson H.;
- Hansen, Aaron R.;
- Lee, Jong-Seok;
- Tsai, Frank;
- Solomon, Benjamin J.;
- Kim, Tae Min;
- Rolfo, Christian;
- Giranda, Vincent;
- Ren, Yixin;
- Liu, Fang;
- Kandala, Bhargava;
- Freshwater, Tomoko;
- Wang, Judy S.
Publication type:
Correction Notice
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Published in:
Investigational New Drugs, 2024, v. 42, n. 1, p. 145, doi. 10.1007/s10637-023-01410-2
By:
- Armstrong, Andrew J.;
- Geva, Ravit;
- Chung, Hyun Cheol;
- Lemech, Charlotte;
- Miller Jr., Wilson H.;
- Hansen, Aaron R.;
- Lee, Jong-Seok;
- Tsai, Frank;
- Solomon, Benjamin J.;
- Kim, Tae Min;
- Rolfo, Christian;
- Giranda, Vincent;
- Ren, Yixin;
- Liu, Fang;
- Kandala, Bhargava;
- Freshwater, Tomoko;
- Wang, Judy S.
Publication type:
Article
Clinical benefit from pemetrexed before and after crizotinib exposure and from crizotinib before and after pemetrexed exposure in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer.
Published in:
2013
By:
- Berge, Eamon M;
- Lu, Xian;
- Maxson, Delee;
- Barón, Anna E;
- Gadgeel, Shirish M;
- Solomon, Benjamin J;
- Doebele, Robert C;
- Varella-Garcia, Maria;
- Camidge, D Ross
Publication type:
journal article
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.
Published in:
Cancer Research & Treatment, 2018, v. 50, n. 3, p. 691, doi. 10.4143/crt.2017.280
By:
- Makoto Nishio;
- Dong-Wan Kim;
- Yi-Long Wu;
- Kazuhiko Nakagawa;
- Solomon, Benjamin J.;
- Shaw, Alice T.;
- Satoshi Hashigaki;
- Emiko Ohki;
- Usari, Tiziana;
- Paolini, Jolanda;
- Polli, Anna;
- Wilner, Keith D.;
- Mok, Tony
Publication type:
Article
Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.
Published in:
Drugs, 2019, v. 79, n. 12, p. 1277, doi. 10.1007/s40265-019-01164-3
By:
- Morris, Tessa A.;
- Khoo, Christine;
- Solomon, Benjamin J.
Publication type:
Article
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells.
Published in:
PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144559
By:
- Solomon, Benjamin J.;
- Desai, Jayesh;
- Rosenthal, Mark;
- McArthur, Grant A.;
- Pattison, Scott T.;
- Pattison, Stacey L.;
- MacDiarmid, Jennifer;
- Brahmbhatt, Himanshu;
- Scott, Andrew M.
Publication type:
Article
Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme.
Published in:
Internal Medicine Journal, 2024, v. 54, n. 7, p. 1087, doi. 10.1111/imj.16348
By:
- Alexander, Marliese;
- Rogers, Jennifer;
- Parakh, Sagun;
- Mitchell, Paul;
- Clay, Timothy D.;
- Kao, Steven;
- Hughes, Brett G. M.;
- Itchins, Malinda;
- Kong, Benjamin Y.;
- Pavlakis, Nick;
- Solomon, Benjamin J.;
- John, Thomas
Publication type:
Article
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors.
Published in:
Cancers, 2024, v. 16, n. 8, p. 1452, doi. 10.3390/cancers16081452
By:
- McLean, Luke S.;
- Lim, Annette M.;
- Angel, Christopher;
- Young, Richard J.;
- Pizzolla, Angela;
- Archer, Stuart;
- Solomon, Benjamin J.;
- Thai, Alesha A.;
- Lewin, Jeremy;
- Rischin, Danny
Publication type:
Article
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma.
Published in:
Cancers, 2021, v. 13, n. 22, p. 5645, doi. 10.3390/cancers13225645
By:
- Thai, Alesha A.;
- Lim, Annette M.;
- Solomon, Benjamin J.;
- Rischin, Danny
Publication type:
Article
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Published in:
Cancers, 2020, v. 12, n. 6, p. 1535, doi. 10.3390/cancers12061535
By:
- Freudenstein, Donald;
- Litchfield, Cassandra;
- Caramia, Franco;
- Wright, Gavin;
- Solomon, Benjamin J.;
- Ball, David;
- Keam, Simon P.;
- Neeson, Paul;
- Haupt, Ygal;
- Haupt, Sue
Publication type:
Article
Complex renal cysts associated with crizotinib treatment.
Published in:
Cancer Medicine, 2015, v. 4, n. 6, p. 887, doi. 10.1002/cam4.437
By:
- Schnell, Patrick;
- Bartlett, Cynthia H.;
- Solomon, Benjamin J.;
- Tassell, Vanessa;
- Shaw, Alice T.;
- Pas, Tommaso;
- Lee, Soo‐Hyun;
- Lee, Geon Kook;
- Tanaka, Kaoru;
- Tan, Weiwei;
- Tang, Yiyun;
- Wilner, Keith D.;
- Safferman, Allan;
- Han, Ji‐Youn
Publication type:
Article
Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression.
Published in:
Science Translational Medicine, 2019, v. 11, n. 495, p. N.PAG, doi. 10.1126/scitranslmed.aaw2293
By:
- Mardiana, Sherly;
- Solomon, Benjamin J.;
- Darcy, Phillip K.;
- Beavis, Paul A.
Publication type:
Article
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers.
Published in:
Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003316
By:
- Katayama, Ryohei;
- Shaw, Alice T.;
- Khan, Tahsin M.;
- Mino-Kenudson, Mari;
- Solomon, Benjamin J.;
- Halmos, Balazs;
- Jessop, Nicholas A.;
- Wain, John C.;
- Alan Tien Yeo;
- Benes, Cyril;
- Drew, Lisa;
- Saeh, Jamal Carlos;
- Crosby, Katherine;
- Sequist, Lecia V.;
- Iafrate, A. John;
- Engelman, Jeffrey A.
Publication type:
Article
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer.
Published in:
Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 171, doi. 10.1007/s40262-023-01309-4
By:
- Chen, Joseph;
- Bearz, Alessandra;
- Kim, Dong-Wan;
- Mamdani, Hirva;
- Bauman, Jessica;
- Chiari, Rita;
- Ou, Sai-Hong Ignatius;
- Solomon, Benjamin J.;
- Soo, Ross A.;
- Felip, Enriqueta;
- Shaw, Alice T.;
- Thurm, Holger;
- Clancy, Jill S.;
- Lee, Kimberly;
- O'Gorman, Melissa;
- Tanski, Cherie;
- Pithavala, Yazdi K.
Publication type:
Article
Clinical Management of Adverse Events Associated with Lorlatinib.
Published in:
Oncologist, 2019, v. 24, n. 8, p. 1103, doi. 10.1634/theoncologist.2018-0380
By:
- Bauer, Todd M.;
- Felip, Enriqueta;
- Solomon, Benjamin J.;
- Thurm, Holger;
- Peltz, Gerson;
- Chioda, Marc D.;
- Shaw, Alice T.
Publication type:
Article

Found: 17